Middleton & Co’s Pediatrix Medical MD Stock Holding History

Middleton & Co’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-11,575	Closed	-$499K	–	163
2017 Q3	$499K	Buy	+11,575	New	+$550K	0.09%	129
2016 Q4	–	Sell	-3,050	Closed	-$202K	–	159
2016 Q3	$202K	Hold	3,050	–	–	0.05%	156
2016 Q2	$221K	Buy	+3,050	New	+$210K	0.05%	149
2016 Q1	–	Sell	-3,050	Closed	-$219K	–	158
2015 Q4	$219K	Buy	+3,050	New	+$226K	0.05%	151

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Middleton & Co's MD Position: Q4 2017 in Review

Middleton & Co sold out of Pediatrix Medical (MD) in Q4 2017, closing a stake of 11,575 shares — an estimated $499K sold.

Middleton & Co first reported a position in MD in Q4 2015 and held it in 4 quarters. The position peaked at $499K in Q3 2017. 330 funds tracked by Wall St. Rank hold MD as of Q4 2017.

Middleton & Co reported no remaining Pediatrix Medical position as of Q4 2017 after selling out during the quarter.
Middleton & Co sold 11,575 Pediatrix Medical shares in Q4 2017, an estimated $499K.
Middleton & Co first reported a position in Pediatrix Medical in Q4 2015 and held it in 4 quarters.
Middleton & Co's Pediatrix Medical position peaked at $499K in Q3 2017.
330 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2017.

Based on Middleton & Co's 13F filing for Q4 2017, filed 25 Jan 2018.